ANL 29.55 Decreased By ▼ -0.25 (-0.84%)
ASC 19.98 Decreased By ▼ -0.42 (-2.06%)
ASL 24.40 Increased By ▲ 0.80 (3.39%)
BOP 8.26 No Change ▼ 0.00 (0%)
BYCO 10.04 Increased By ▲ 0.16 (1.62%)
FCCL 21.95 Increased By ▲ 0.10 (0.46%)
FFBL 27.00 Increased By ▲ 0.09 (0.33%)
FFL 19.33 Decreased By ▼ -0.67 (-3.35%)
FNEL 8.42 Decreased By ▼ -0.32 (-3.66%)
GGGL 25.16 Decreased By ▼ -1.24 (-4.7%)
GGL 43.60 Decreased By ▼ -2.44 (-5.3%)
HUMNL 6.92 Decreased By ▼ -0.13 (-1.84%)
JSCL 21.50 Decreased By ▼ -0.12 (-0.56%)
KAPCO 39.00 Increased By ▲ 0.30 (0.78%)
KEL 3.83 Decreased By ▼ -0.07 (-1.79%)
MDTL 3.52 Decreased By ▼ -0.04 (-1.12%)
MLCF 43.50 No Change ▼ 0.00 (0%)
NETSOL 157.00 Decreased By ▼ -1.50 (-0.95%)
PACE 7.20 Decreased By ▼ -0.25 (-3.36%)
PAEL 33.28 Decreased By ▼ -0.37 (-1.1%)
PIBTL 10.95 Decreased By ▼ -0.05 (-0.45%)
POWER 9.06 Decreased By ▼ -0.14 (-1.52%)
PRL 23.10 Increased By ▲ 0.10 (0.43%)
PTC 11.88 Increased By ▲ 0.28 (2.41%)
SILK 1.72 Decreased By ▼ -0.11 (-6.01%)
SNGP 50.74 Increased By ▲ 0.94 (1.89%)
TELE 15.17 Increased By ▲ 0.37 (2.5%)
TRG 160.25 Increased By ▲ 0.80 (0.5%)
UNITY 40.55 Increased By ▲ 0.10 (0.25%)
WTL 3.43 Decreased By ▼ -0.16 (-4.46%)
BR100 5,093 Decreased By ▼ -3.1 (-0.06%)
BR30 25,710 Decreased By ▼ -44.74 (-0.17%)
KSE100 47,312 Decreased By ▼ -5.7 (-0.01%)
KSE30 18,963 Decreased By ▼ -10.86 (-0.06%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,209
7624hr
Pakistan Cases
1,020,324
4,49724hr
7.53% positivity
Sindh
374,434
Punjab
354,904
Balochistan
30,019
Islamabad
86,602
KPK
142,799
World

UK reports five cases of rare blood clots in AstraZeneca rollout, continues use of shot

  • Concerns about reports of blood clots, along with low platelet levels, have led to European countries including Germany to pause the rollout of the shot while the cases are investigated. *"The available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by COVID-19 Vaccine AstraZeneca," the MHRA said.
18 Mar 2021

LONDON: Britain's medicines regulator said there had been five cases of a rare type of blood clot in cerebral veins among people given AstraZeneca's vaccine but said the shot should still be used as there was no evidence it caused blood clots.

Concerns about reports of blood clots, along with low platelet levels, have led to European countries including Germany to pause the rollout of the shot while the cases are investigated.

However, Britain's Medicines and Healthcare products Regulatory Agency said that use of the vaccine should continue while five reports were investigated

"The available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by COVID-19 Vaccine AstraZeneca," the MHRA said.

"A further, detailed review into five UK reports of a very rare and specific type of blood clot in the cerebral veins (sinus vein thrombosis) occurring together with lowered platelets (thrombocytopenia) is ongoing."

Britain has administed 11 million doses of AstraZeneca's vaccine.